From: Influenza co-infection associated with severity and mortality in COVID-19 patients
Baseline variables | All patients | Non-ICU | ICU | P-value |
---|---|---|---|---|
 | (N = 48) | N = 34 (71%) | N = 14 (29%) |  |
Demographics | Â | Â | Â | Â |
Age | Â | Â | Â | Â |
Median | 52 ± 18 | 46 ± 18 | 62 ± 15 |  |
Range | 1–92 | 1–92 | 25–74 |  |
Gender | Â | Â | Â | Â |
 Men | 37 (77%) | 26 (70%) | 11 (30%) | p = 0.87* |
 Women | 11 (23%) | 8 (73%) | 3 (27%) |  |
Characteristics | Â | Â | Â | Â |
Co-infection | Â | Â | Â | Â |
 Co-infection | 34 (71%) | 25 (74%) | 9 (26%) | p = 0.52* |
 No co-infection | 14 (29%) | 9 (64%) | 5 (36%) |  |
 Multiple co-infections | 11 (32%) | 9 (82%) | 2 (18%) | p = 0.49* |
 Single co-infection | 23 (68%) | 16 (71%) | 7 (29%) |  |
Case fatality rate | 9 (19%) | – | 9 (100%) |  |
Comorbidities | Â | Â | Â | Â |
Cardiovascular disease | 2 (4%) | 0 (0%) | 2 (100%) | p = 0.22* |
Chronic kidney disease | 5 (10%) | 4 (80%) | 1 (20%) | p = 0.63* |
Diabetes | 26 (54%) | 22 (85%) | 4 (15%) | p = 0.02** |
Others | 13 (27%) | 6 (46%) | 7 (54%) | p = 0.02** |
Serological markers (median) | Â | Â | Â | Â |
 d-dimer (0–0.5) | 1.6 | 1.7 | 1.4 | p = 0.25* |
 LDH (98–192) | 336 | 335 | 349 | p = 0.12* |
 Troponin T (0–0.07) | 0.01 | 0.01 | 0.05 | p < 0.05** |